The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
The launch of Chlorpromazine Hydrochloride for Injection is the latest in a series of recent product launches from Piramal Critical Care
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Hampton joins PCC from Accord Healthcare, where he was the President and responsible for accelerating the firm's growth strategy
New manufacturing facility dedicated to the production of active pharmaceutical ingredients (APIs) and high potency active pharmaceutical ingredients (HPAPIs)
ADCelerate delivers Phase I appropriate antibody-drug conjugate (ADC) drug substance and drug product for Investigational New Drug (IND) submission
Plant is part of the company's CAD $30 million capital investment in the site
Subscribe To Our Newsletter & Stay Updated
